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Many human lymphocyte cell  lines have  been  established  from subjects  with  a 
variety of hematopoietic disorders as well as from normal individuals. Most of these 
cell lines have properties of bone marrow-derived lymphocytes, or B  cells  (1-5): im- 
munoglobulins can be detected  in their  cytoplasm, on their  surface  membranes,  or 
secreted into the surrounding medium. Another nearly universal feature is the presence 
in the cells of Epstein-Barr virus (EBV) 1 or EBV antigens (5-8). 
We have recently shown (9) that cell lines CCRF-CEM and HSB-2, derived from 
two  children  with  leukemia  secondary  to  lymphosarcoma,  have  T-cell properties, 
as do tumor cells obtained directly from other children with lymphoblastic lymphoma. 
These two lines,  extensively studied by Adams, Foley, and their colleagues (10-13), 
possess characteristics of malignant lymphoblasts, not only by their ability to mul- 
tiply indefinitely in vitro,  but also by their  oncogenic behavior when injected  into 
untreated newborn hamsters. 
The only other cell  lines described with T-cell properties  are the  "MOLT" 
cell lines isolated and characterized by Minowada, et al.  (14). These four lines, 
derived from a  19-year old male with acute lymphoblastic leukemia, lack EBV 
and EBV  antigens  (15).  Because  EBV or EBV  antigens  have been  found in 
every B-cell line so studied, the possibility that T-cell lines derived from malig- 
nant  lymphoblasts  lack  EB  virus  requires  further  investigation.  This  report 
describes  studies  of cell  lines  CCRF-CEM  and  HSB-2 which,  in  addition  to 
further demonstrating that they share many properties with normal peripheral 
blood T  cells, indicate that they are EB virus-negative. 
Materials and Methods 
Cell Cultures.--The sources and methods of maintaining cultures of cell lines CCRF-CEM, 
HSB-2, CCRF-SB,  and Raji  have been previously reported  (9). Cell line P8HRI (16) was 
maintained  in a similar manner. 
T- and B-Cell Characterizatlon.--The methods  for detection  of erythrocyte-binding  lyre- 
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phocytes,  complement  receptor-bearing  lymphocytes,  and surface  immunoglobulin-beafing 
lymphocytes were as previously described  (9). 
Antiscra.--Equine  antihuman  thymocyte  gamma  globulin  (Upjohn  Co.,  Kalamazoo, 
Mich.) was dialyzed extensively against  0.15 M NaC1, heat inactivated  at 56  ° for 30 rain, 
and absorbed with pooled human type AB-positive erythrocytes.  Rabbit anfisera  to lym- 
phocyte call lines were raised by twice injecting  108-109 cells i.v.  at  10-day intervals  and 
bleeding 7-10 days after the last injection. Serum was heat inactivated  and stored at --20°C. 
InhiMtion  of Rosette Formation.--Diluted  antiserum  (0.05 ml)  was added  to aliquots  of 
cells (0.25 ml) at l0  s cells/ml of Hanks' basal salt solution. Mter 15 min at room temperature, 
0.5o/0 washed  sheep  erythrocytes  (0.25 ml)  were added  and  rosette  formation  was  deter- 
mined (9). 
Detection of EBV Antigons.--Previously described methods to detect  EB viral capsid an- 
tigen (VCA) (17), and EB viral nuclear antigen, EBNA (18), were employed using fluorescein 
isothionate  conjugated  (FITC)  goat polyvalent  antihuman Ig and FITC goat anfihuman 
~IC/fllA globulin obtained from Hyland Div., Travenol Laboratories, Inc., Costa Mesa, Calif. 
Two human sera containing EB viral capsid antibody at dilutions of 1:80 and 1:360 respec- 
tively, and two human sera without viral capsid antibody at 1: 5 dilutions were selected. The 
former two sera contain antibody directed against EBNA; the latter two do not. The VCA 
test antigen was acetone-fixed PsHR1 cells; the EBNA test antigen was acetone-fixed Raji 
cells. 
RESULTS 
Table I  shows that cell lines CCRF-SB, Raji,  and PsHR1, like most previ- 
ously described  lymphocyte cell  lines,  are  B  cells.  They possess  complement 
receptors and surface immunoglobulin. In contrast,  cell lines CCRF-CEM and 
HSB-2 are T  cells. They form rosettes with sheep erythrocytes and  lack com- 
plement  receptors  and  surface  immunoglobulin. 
Examination of various aspects of rosette formation reveals many additional 
similarities  between  these  T-cell  lines  and  normal  peripheral  blood  T  cells 
(Table II): More rosettes form after incubation at 4°C than  after incubation 
at 37°C,  and rosette formation occurs to  varying  degrees,  with  erythrocytes 
from different species.  Of note is  the observation  that,  like normal human T 
cells, 2 under appropriate temperature conditions, both CCRF-CEM and HSB-2 
form rosettes  with  human  erythrocytes.  In  all  of these instances,  binding  of 
erythrocytes to the cell surface is weak since even brief, but vigorous agitation 
totally disrupts the rosettes. 
A comparison of the ability of antisera raised against T- and B-cell lines and 
against  human  thymocytes to  inhibit  in  vitro  rosette  formation  with  sheep 
erythrocytes is shown in Table III. Rabbit antisera to the T-cell line CCRF- 
CEM as well as equine antihuman thymocyte gamma globulin inhibit rosette 
formation with sheep erythrocytes by normal peripheral  blood T  cells as well 
as by both T-cell lines. In contrast, rabbit antisera to the B-cell lines CCRF-SB 
and Raji have no effect on rosette formation even though they possess the same 
degree of reactivity  as  antithymocyte serum  and  antiserum  to  CCRF-CEM 
2 Kaplan, J. Human T cells from rosettes with autologous and homologous human erythro- 
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TABLE I 
T- and  B-Cell  Markers on Cells from Established  Lymphoid  Cell Lines 
Cell line  EL*  CRL*  SIg* 
%  %  % 
CCRF-CEM  51  0  0 
CCRF-HSB-2  43  0  0 
CCRF-SB  0  2  90 
Raji  0  63  96 
Peripheral blood of eight normal  60  -4-  8~  17  -4-  4  25  :t:  5 
adults 
* Average of three determinations of each cell line. EL, erythrocyte-binding lymphocytes; 
CRL, complement receptor lymphocyte; and SIg, surface immunoglobulin lymphocytes. 
Mean :k SD. 
TABLE II 
Rosette Formation  by  Lymphocyte  Cell Lines at Different  Temperatures  and  with Erythrocytes 
from Different  Species 
Cells 
% rosettes formed with 
sheep erythrocytes after 
incubation at: 
% rosettes formed at 4  ° with erythrocytes from: 
4*  37  °  Dog  Goat  Horse  Hamster  Human* 
Peripheral blood  55  1  11  14  11  0  8 
CCRF-CEM  31  15  25  11  5  0  5 
CCRF-HSB-2  26  7  57  24  25  5  5 
Raji  0  0  0  0  0  0  0 
* Read at 4  °. 
TABLE III 
The  Effect  of Antiserum  to  Human  Thymocytes  and  to  Lymphocyte  Cell Lines  on  Sheep 
Erythrocyte  Binding by Cell Lines tISB-2 and CEM 
Serum  Dilution 
Inhibition of erythrocyte binding* by: 
CCRF-CEM  HSB-2 
Anti-CCRF-CEM  1 : 60  100  100 
Anti-CCRF-SB  1 : 60  9  0 
Anti-Raji  1 : 60  0  0 
Anti-human thymocyte  1 : 100  100  100 
* %  inhibition of rosette-forming cells (RFC)  = 
100 X  (% RFC~on,rol) -- (% RFC  .....  ) 
(% RFCoont~o,). 
when  assayed  for  cytotoxicity to  peripheral  blood  lymphocytes  and  cell line 
lymphoblasts.  These findings indicate  that  the T-cell lines,  but not the B-cell 
lines,  share  a  common  surface  antigen  with  normal  peripheral  blood  T  cells. 
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T-cell properties of cell lines CCRF-CEM and HSB-2 make them uniquely dif- 
ferent from most other established lymphocyte cell lines, they were examined 
for the presence or absence of EB  viral  antigens.  The results of testing  for 
VCA and for EBNA are shown in Table IV. 
As previously reported (19), cell line P3HR1 shows a positive reaction for VCA 
consisting  of intense  bubbly  fluorescence seen  in  approximately 5 %  of  the 
cells,  while  the  VCA-negative  cell  line  Raji  shows  only  weak  background 
fluorescence.  A  similar  negative  VCA  reaction  is  seen  with  cell  lines 
CCRF-SB, HSB-2, and CCRF-CEM.  When tested for EBNA, cell line Rail, 
as previously demonstrated (18)  exhibits bright, feathery nuclear fluorescence 
in over 90%  of the cells.  A  similar positive reaction is seen with  the B-cell 
TABLE IV 
Testing  of  Lymphocyte  Cell  Lines for  EB  VCA  and  EBNA 
Cells  Reference  serum 
(EBV antibody*) 
Cells staining for: 
VCA  EBNA 
% 
P3HR1  Positive  5  90 
Negative  0  0 
Raji  Positive  0  90 
Negative  0  0 
CCRF-SB  Positive  0  90 
Negative  0  0 
CCRF-HSB-2  Positive  0  0 
Negative  0  0 
CCRF-CEM  Positive  0  0 
Negative  0  0 
* All sera diluted 1  : I0. 
line CCRF-SB. In contrast, the T-cell lines CCRF-CEM  and HSB-2 contain 
no positively stained cells. Their nuclei are uniformly dark against weak back- 
ground cytoplasmic autofluorescence. 
DISCUSSION 
Human T  cells form nonimmune rosettes with sheep erythrocytes (20,  21) 
whereas human B  cells have complement receptors (22)  and surface immuno- 
globulins  (23).  By use of these markers,  cell lines  CCRF-CEM  and  HSB-2 
resemble "  normal" human T  lymphocytes. They bind sheep erythrocytes and 
erythrocytes of certain  other  species,  this  binding  is  inhibited  to  a  greater 
degree by heterologous antiserum to T-cell lines than by heterologous antiserum 
to B-cell lines, and they lack complement receptors and surface immunoglob- 
ulin. 
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dence  suggests  that  both  of  these  lines  represent  malignant  T  cells.  Both 
CCRF-CEM and HSB-2 originated from peripheral blood of two children with 
lymphoblastic lymphoma (12). Tumor cells obtained directly from four children 
with lymphoblastic lymphoma have been shown to have T-cell properties (9). 
No lymphocyte cell line with T-cell properties has yet been established from a 
normal individual. Adams and his co-workers have studied the ability of these 
and other cell lines to cause tumors in hamsters. They have shown (13)  that 
cell lines CCRF-CEM, HSB-2, and a third cell line from a child with lympho- 
blastic  lymphoma,  H-HM-1,  induce tumors  in untreated newborn hamsters 
which progress to leukemia. The tumor cells do not produce immunoglobulin. 
No other cell lines tested cause tumors in untreated hamsters. However, after 
antithymocyte  serum  treatment  of  animals,  a  variety  of  lymphocyte  cell 
lines, including cell lines CCRF-SB  and cell lines from normal individuals, do 
cause tumors in newborn hamsters. These do not progress to leukemia.  Cells 
from  these  tumors,  however, like  B  cells,  produce human  immunoglobulin. 
These findings,  taken  together,  support  the  concept that  cell lines  CCRF- 
CEM and HSB-2 represent malignant T  lymphocytes. 
In contrast, cell line CCRF-SB, which was established from the same patient 
as cell line HSB-2, has B rather than T-cell properties. CCRF-SB does not form 
rosettes  with  sheep  erythrocytes and  does have membrane  complement re- 
ceptors and surface immunoglobulins. All lymphocyte cell lines obtained from 
normal individuals are B cells (1, 2, 5), therefore cell line CCRF-SB probably 
originated  from  a  normal,  albeit  EBV-infected,  B-lymphocyte population 
which co-existed with the malignant T lymphoblasts from which cell line HSB-2 
originated. 
EB virus apparently only infects B  cells: Burkitt's lymphoma tumor cells 
contain EB viral antigens and are B cells; B cells, but not T  cells, have surface 
receptors for EB  virus  (15); and finally, evidence of EB  virus or viral anti- 
gens is found in all B-cell lines but not, as shown here, in T-cell lines. Like the 
previously described MOLT T-cell lines  (15),  CCRF-CEM and  HSB-2  are 
EB virus-negative, even when examined for the EBNA which has been found 
in all cell lines possessing EBV genorne (18). 
That EB virus can induce the establishment of lymphocyte cell lines from 
fetal lymphoid tissue,  and  that  establishment of lymphocyte cell lines from 
normal individuals can only occur if the donors have serological evidence of 
prior EBV infection, has suggested that EB virus infection is a prerequisite for 
sustained  in  vitro  lymphocyte proliferation.  The EBV-negative T-cell lines 
CCRF-CEM,  HSB-2, and MOLT appear to be exceptions to this rule. 
Factors other than EBV genome must be responsible for their continuous 
in vitro growth. HSB-2 was originally established from leukemic cells hetero- 
transplanted  into newborn hamsters.  However, passage  through hamsters  is 
not a necessary condition for establishment of T-cell lines since CCRF-CEM 
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samples. Since all the known T-cell lines originate from subjects with leukemia 
while  no  T-cell  lines  have  yet  been  established  from  normals,  and  since 
cell  lines  CCRF-CEM  and  HSB-2  both  possess  unique  in  vivo  oncogenic 
behavior in hamsters, their continuous in vitro growth probably reflects their 
origin from malignant tumor cells. Perhaps they possess genetic material of a 
virus which,  like EB virus (6,  24-26),  can induce both long term in vitro cell 
growth as well as in vivo tumor growth. If so, the ready availability of these 
malignant T-lymphocyte cell  lines  should  facilitate  the  search  for  a  human 
leukemia-lymphoma virus. 
SUMMARY 
Two  lymphoblastoid  lines,  CCRF-CEM  and  HSB-2,  with  properties  of 
malignant  cells,  derived  from children  with  leukemia  secondary  to  lympho- 
sarcoma, have T-cell properties and lack Epstein-Barr virus antigens. 
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